Your browser doesn't support javascript.
loading
The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants.
Wang, Shu; Zhu, Yuqi; Qian, Xiaohan; Ding, Tianling; Yuan, Yan; Li, Yuan; Wu, Hanfeng; Chen, Tong.
Affiliation
  • Wang S; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhu Y; Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
  • Qian X; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Ding T; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Yuan Y; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Li Y; Department of Radiology, Huashan Hospital, Fudan University, Shanghai, China.
  • Wu H; Department of Neurosurgery, Shanghai Gamma Hospital, China.
  • Chen T; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
Adv Clin Exp Med ; 32(8): 855-863, 2023 Aug.
Article in En | MEDLINE | ID: mdl-36881367
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Central Nervous System Neoplasms / Lymphoma Type of study: Observational_studies Limits: Humans Language: En Journal: Adv Clin Exp Med Year: 2023 Document type: Article Affiliation country: China Country of publication: Polonia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Central Nervous System Neoplasms / Lymphoma Type of study: Observational_studies Limits: Humans Language: En Journal: Adv Clin Exp Med Year: 2023 Document type: Article Affiliation country: China Country of publication: Polonia